Pozelimab Emerging Drug Insight and Market Forecasts, 2019-2032: An Investigational, Fully Human mAb Designed to Block Complement Factor C5 and Prevent the Destruction of Red Blood Cells

Posted on by

DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Pozelimab Emerging Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about pozelimab for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.